Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK

Ioanna Vlachaki, Daniela Zinzi, Edel Falla*, Theo Mantopoulos, Holly Guy, Jasimran Jandu, Andrew Dodgson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK'. Together they form a unique fingerprint.

Business & Economics

Medicine & Life Sciences

Social Sciences